Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fortrea Holdings Inc. | Director | Restricted Stock Unit | 7.28K | $267K | $36.70 | May 14, 2024 | Direct |
BIOCRYST PHARMACEUTICALS INC | Director | Common Stock | 27.7K | $166K | $6.00 | Jun 17, 2024 | Direct |
BIOCRYST PHARMACEUTICALS INC | Director | Automatic Stock Option Grant | 49.9K | Jun 12, 2024 | Direct | ||
Novan, Inc. | Director | Common Stock | 25.2K | Jun 27, 2023 | Direct | ||
Radius Health, Inc. | Director | Common Stock | 0 | $10.00 | Aug 15, 2022 | Direct | |
Radius Health, Inc. | Director | Stock Option (Right to Buy) | 0 | $4.16 | Aug 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCRX | BIOCRYST PHARMACEUTICALS INC | Jun 17, 2024 | 1 | -$28.1K | 4 | Jun 17, 2024 | Director |
BCRX | BIOCRYST PHARMACEUTICALS INC | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
FTRE | Fortrea Holdings Inc. | May 14, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
FTRE | Fortrea Holdings Inc. | May 14, 2024 | 0 | $0 | 3 | May 16, 2024 | Director |
NOVNQ | Novan, Inc. | Jun 27, 2023 | 1 | -$4.72K | 4 | Jun 27, 2023 | Director |
BCRX | BIOCRYST PHARMACEUTICALS INC | Jun 13, 2023 | 3 | -$31.9K | 4 | Jun 15, 2023 | Director |
NOVNQ | Novan, Inc. | Jun 6, 2023 | 3 | $0 | 4 | Jun 8, 2023 | Director |
RDUS | Radius Health, Inc. | Aug 15, 2022 | 2 | -$91K | 4 | Aug 15, 2022 | Director |
NOVNQ | Novan, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
BCRX | BIOCRYST PHARMACEUTICALS INC | Jun 7, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
BCRX | BIOCRYST PHARMACEUTICALS INC | Feb 8, 2022 | 1 | $0 | 4 | Feb 10, 2022 | Director |
BCRX | BIOCRYST PHARMACEUTICALS INC | Feb 8, 2022 | 0 | $0 | 3 | Feb 10, 2022 | Director |
RDUS | Radius Health, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 25, 2022 | Director |
NOVNQ | Novan, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |